Create a 30‑item case‑based multiple‑choice questionnaire on retinal vascular occlusions (central retinal vein occlusion, branch retinal vein occlusion, central retinal artery occlusion, branch retinal artery occlusion) for a retina fellowship examination.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

30-Item Case-Based MCQ Questionnaire: Retinal Vascular Occlusions

CENTRAL RETINAL VEIN OCCLUSION (CRVO)

Case 1: A 68-year-old hypertensive man presents with sudden painless vision loss (20/200) in his right eye. Fundus examination reveals diffuse retinal hemorrhages in all four quadrants, dilated tortuous veins, cotton-wool spots, and optic disc edema.

Question 1: What is the MOST important immediate next step in management?

  • A) Start oral aspirin 325mg daily
  • B) Perform fluorescein angiography to assess degree of ischemia
  • C) Initiate intravitreal anti-VEGF therapy immediately
  • D) Refer to stroke center within 24 hours

Answer: B 1, 2


Question 2: Fluorescein angiography shows >10 disc areas of capillary non-perfusion. What is the PRIMARY concern requiring closest monitoring?

  • A) Cystoid macular edema development
  • B) Anterior segment neovascularization and neovascular glaucoma
  • C) Epiretinal membrane formation
  • D) Vitreous hemorrhage

Answer: B 1, 2


Case 2: A 55-year-old diabetic woman with CRVO develops macular edema with central subfield thickness of 520 microns on OCT. Vision is 20/80.

Question 3: What is the FIRST-LINE treatment for vision-threatening macular edema in CRVO?

  • A) Intravitreal corticosteroids
  • B) Panretinal photocoagulation
  • C) Intravitreal anti-VEGF agents
  • D) Observation for 3 months

Answer: C 1, 2


Question 4: The patient asks about steroid injections instead. What is the MOST significant risk you must counsel regarding intravitreal corticosteroids?

  • A) Endophthalmitis
  • B) Retinal detachment
  • C) Glaucoma and cataract formation
  • D) Vitreous hemorrhage

Answer: C 1, 2


Case 3: A 62-year-old man presents with non-ischemic CRVO (visual acuity 20/40, minimal capillary dropout on FA).

Question 5: What is the MOST critical concept to communicate to this patient about his diagnosis?

  • A) Vision will spontaneously improve in 90% of cases
  • B) Non-ischemic CRVO can convert to ischemic type requiring vigilant monitoring
  • C) No treatment is ever needed for non-ischemic CRVO
  • D) Laser photocoagulation should be performed immediately

Answer: B 1, 2


Question 6: Which systemic evaluation is ESSENTIAL in all CRVO patients?

  • A) Hypercoagulability workup only in patients under 50
  • B) Carotid duplex ultrasound
  • C) Optimization of hypertension, diabetes, lipids, and IOP with communication to primary care
  • D) Temporal artery biopsy

Answer: C 1, 2


Case 4: A patient with ischemic CRVO returns 6 weeks later with IOP of 42 mmHg and rubeosis iridis.

Question 7: What examination technique is ESSENTIAL for detecting early angle neovascularization?

  • A) Optical coherence tomography
  • B) Gonioscopy
  • C) B-scan ultrasonography
  • D) Fundus autofluorescence

Answer: B 2


Question 8: The patient develops iris neovascularization. What is the RECOMMENDED treatment?

  • A) Topical steroids
  • B) Intravitreal anti-VEGF alone
  • C) Panretinal photocoagulation
  • D) Immediate trabeculectomy

Answer: C 1


BRANCH RETINAL VEIN OCCLUSION (BRVO)

Case 5: A 58-year-old hypertensive woman presents with superotemporal BRVO. Vision is 20/30 with macular edema on OCT.

Question 9: Where does BRVO typically occur anatomically?

  • A) At the optic nerve head
  • B) At an arteriovenous crossing point with common adventitial sheath
  • C) In the peripheral retina only
  • D) At the foveal avascular zone

Answer: B 1


Question 10: What is the FIRST-LINE treatment for macular edema causing vision loss in BRVO?

  • A) Macular grid laser photocoagulation
  • B) Intravitreal anti-VEGF agents
  • C) Observation for 6 months
  • D) Intravitreal triamcinolone

Answer: B 1


Case 6: A patient with BRVO develops retinal neovascularization in the affected quadrant.

Question 11: What is the APPROPRIATE laser treatment?

  • A) Panretinal photocoagulation to all four quadrants
  • B) Sectoral (angiography-guided) laser photocoagulation to affected area
  • C) Macular grid laser only
  • D) No laser treatment indicated

Answer: B 3


CENTRAL RETINAL ARTERY OCCLUSION (CRAO)

Case 7: A 72-year-old man presents 2 hours after sudden painless vision loss (counting fingers). Fundus shows retinal whitening, cherry-red spot, and boxcar segmentation in arterioles.

Question 12: What does boxcar segmentation in retinal arterioles indicate?

  • A) Venous stasis
  • B) Slow, segmented blood flow characteristic of embolic arteritis
  • C) Normal arterial flow
  • D) Choroidal ischemia

Answer: B 4


Question 13: What is the MOST urgent immediate action?

  • A) Perform ocular massage
  • B) Immediate referral to nearest stroke center for acute intervention
  • C) Start oral aspirin
  • D) Perform anterior chamber paracentesis

Answer: B 1


Question 14: What is the stroke risk in the first 1-4 weeks following CRAO?

  • A) <1%
  • B) 3-6%
  • C) 10-15%
  • D) >20%

Answer: B 4


Case 8: A 76-year-old woman with CRAO also has jaw claudication, temporal headache, and ESR 95 mm/hr.

Question 15: What is the MOST likely diagnosis requiring immediate treatment?

  • A) Carotid stenosis
  • B) Giant cell arteritis
  • C) Atrial fibrillation
  • D) Hypercoagulable state

Answer: B 1


Question 16: What is the IMMEDIATE treatment before temporal artery biopsy?

  • A) Wait for biopsy results before treatment
  • B) Urgent systemic corticosteroid therapy
  • C) Intravitreal anti-VEGF
  • D) Anticoagulation

Answer: B 1, 5


Question 17: In a patient over 50 with CRAO, what is the PRIMARY reason for urgent GCA evaluation?

  • A) To improve vision in the affected eye
  • B) To preserve vision in the contralateral eye
  • C) To prevent stroke
  • D) To diagnose carotid disease

Answer: B 1


Case 9: A 45-year-old healthy woman presents with CRAO.

Question 18: What systemic workup is MOST appropriate for this patient?

  • A) Embolic workup (carotid duplex, echocardiogram)
  • B) Vasculitis and hypercoagulability workup
  • C) Giant cell arteritis workup
  • D) No workup needed

Answer: B 1


Case 10: A patient asks about treatment options to reverse vision loss from CRAO.

Question 19: What is the EVIDENCE-BASED answer regarding treatments for CRAO?

  • A) Hyperbaric oxygen is proven effective
  • B) Thrombolysis is standard of care
  • C) There are no proven treatments to reverse vision loss from CRAO
  • D) Anti-VEGF injections restore vision in most cases

Answer: C 1


BRANCH RETINAL ARTERY OCCLUSION (BRAO)

Case 11: A 65-year-old man presents with inferior altitudinal visual field defect. Fundus shows superior retinal whitening in a wedge-shaped distribution.

Question 20: What is the MOST likely diagnosis?

  • A) CRVO
  • B) BRVO
  • C) Superior BRAO
  • D) Optic neuritis

Answer: C 1


Question 21: What systemic evaluation should be performed for BRAO?

  • A) No evaluation needed for asymptomatic BRAO
  • B) Immediate stroke center referral for acute symptomatic BRAO
  • C) Only check blood pressure
  • D) Temporal artery biopsy in all cases

Answer: B 1


Case 12: A patient with BRAO has a Hollenhorst plaque at the bifurcation of a retinal arteriole.

Question 22: What does this finding indicate?

  • A) Venous thrombosis
  • B) Cholesterol embolus from carotid or cardiac source
  • C) Giant cell arteritis
  • D) Diabetic retinopathy

Answer: B 1


GIANT CELL ARTERITIS (GCA)

Case 13: A 78-year-old woman with sudden vision loss has ESR 88 mm/hr and CRP 6.5 mg/dL.

Question 23: What is the sensitivity of elevated CRP for diagnosing GCA?

  • A) 50%
  • B) 70%
  • C) 90%
  • D) 99%

Answer: C 1, 5


Question 24: What is the negative likelihood ratio of a normal CRP in suspected GCA?

  • A) 0.10
  • B) 0.40
  • C) 0.70
  • D) 0.90

Answer: B 1, 5


Case 14: A 68-year-old man with CRAO has normal ESR (18 mm/hr) and normal CRP (0.8 mg/dL) but has jaw claudication.

Question 25: What should you do?

  • A) GCA is excluded by normal inflammatory markers
  • B) Jaw claudication upgrades suspicion for GCA despite normal markers; proceed with workup
  • C) Repeat labs in 1 week
  • D) No further GCA evaluation needed

Answer: B 1, 5


Question 26: Which physical finding has the HIGHEST positive likelihood ratio for GCA?

  • A) Headache (LR+ 1.1)
  • B) Scalp tenderness (LR+ 1.9)
  • C) Temporal artery thickening (LR+ 4.7)
  • D) Constitutional symptoms (LR+ 1.2)

Answer: C 1


Case 15: A patient with suspected GCA has anterior ischemic optic neuropathy (AION).

Question 27: What is the sensitivity of AION for GCA?

  • A) 6%
  • B) 24%
  • C) 52%
  • D) 88%

Answer: B 1


Question 28: What percentage of GCA patients have CRP elevated at diagnosis?

  • A) 50%
  • B) 70%
  • C) >95%
  • D) 100%

Answer: C 5


COMBINED OCCLUSIONS

Case 16: A 56-year-old man presents with cream-colored retinal edema along a macular branch artery, delayed fluorescein filling, AND dilated tortuous veins with scattered hemorrhages.

Question 29: What is the MOST likely diagnosis?

  • A) CRVO alone
  • B) CRAO alone
  • C) Combined CRAO and CRVO
  • D) Diabetic retinopathy

Answer: C 6


Question 30: A 42-year-old man with asthma and hypereosinophilia develops combined central retinal artery and vein occlusion. What underlying systemic disease should be suspected?

  • A) Behçet's disease
  • B) Churg-Strauss syndrome (eosinophilic granulomatosis with polyangiitis)
  • C) Systemic lupus erythematosus
  • D) Sarcoidosis

Answer: B 7


ANSWER KEY SUMMARY: 1-B, 2-B, 3-C, 4-C, 5-B, 6-C, 7-B, 8-C, 9-B, 10-B, 11-B, 12-B, 13-B, 14-B, 15-B, 16-B, 17-B, 18-B, 19-C, 20-C, 21-B, 22-B, 23-C, 24-B, 25-B, 26-C, 27-B, 28-C, 29-C, 30-B

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ischemic vs Non-Ischemic CRVO: Treatment and Prognosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Distinguishing Retinal Arteritis from Retinal Phlebitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria for Giant Cell Arteritis (GCA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Combined occlusion of the central retinal artery and vein.

Japanese journal of ophthalmology, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.